Management TeamOur Experts

Board certified in both clinical pharmacology and internal medicine, Dr. Wagner is author of more than 40 peer reviewed publications and over 100 published abstracts. Dr. Wagner has previously served as the head of intensive care medicine at the The Deutsches Herzzentrum Berlin (DHZB, German Heart Institute Berlin). He is a faculty member of Charité - Universitätsmedizin Berlin and founded Charité Research Organisation in conjunction with the university hospital to provide a platform for bringing patients, clinical expertise and diagnostic technologies into the exploratory clinical development setting.

Dr. Hüser has a long standing track record in drug development and contributes a wide-ranging knowledge of biotechnology, pharmaceutical research and project management. Awarded an MBA in entrepreneurial management in 2005, Dr. Hüser also holds a Ph.D. in molecular biology.

Mr. Stein has more than 10 years experience of the CRO industry, covering financial administration across all phases of development. Mr. Stein has a professional background specializing in the areas of financial auditing and taxation.

Mr. Burrell has served in the CRO industry for more than 10 years, covering Business Development. In particular Mr. Burrell has focused on working with the pharmaceutical and biotech industries with respect to exploratory clinical development.

Dr. Hertrampf is board certified in clinical pharmacology. Dr. Hertrampf has 17 years regulatory experience gained at the German competent authority, “BfArM”. There she was head of the “Angiology, Nephrology, Hypertension, Haemostaseology” unit and acting head of the “Cardiovascular System” unit.

Prof. Jähnchen is board certified in clinical pharmacology and pharmacology/toxicology. He has been a Professor Emeritus of the Johannes-Gutenberg University Mainz since 2003. Prof. Jähnchen was the founder of the Department of Clinical Pharmacology at the Herzzentrum, Bad Krozingen, where he served as the Director of the Institute for more than two decades. He is the author of numerous peer-reviewed publications and book chapters. He has been a member of the "Kommission A" of the German competent authority, “BfArM", since 1997 and a consultant for the German BMBF in the field of clinical pharmacology since 1998.